{"id":49839,"topic":"peptides","source":"Nutraceutical Business Review","title":"Health Canada bans Canlab Research from selling injectable peptides - Nutraceutical Business Review","url":"https://nutraceuticalbusinessreview.com/health-canada-bans-canlab-research-selling-injectable-peptides","url_hash":"9789a67e2d839caee6d8be0cfe988990d4fd65e4","author":"","summary":"Health Canada bans Canlab Research from selling injectable peptides Nutraceutical Business Review","content":"Health Canada has been granted a permanent injunction against Canlab Research and its representatives by the Superior Court of Québec, preventing Canlab Research from selling unauthorised injectable peptides in Canada.\nAccording to Health Canada, Canlab Research — a Québec-based online retailer — had been selling unauthorised peptide drugs on various websites and promoting them with many unproven health claims.\nIt had continued despite repeated enforcement actions by Health Canada, including a Ministerial Order directing the company to cease advertising and selling unauthorised health products because of the health risks to Canadians.\nSelling unauthorised prescription drugs or making false or misleading claims to prevent, treat or cure illnesses is illegal in Canada.\nInjunction blocks Canlab’s sales and advertising\nUnder the injunction, Canlab Research cannot manufacture, test, distribute or sell unauthorised injectable peptides. It is also banned from assisting others in doing the same.\nCanlab Research cannot advertise (or assist others in advertising) these products, including on any website or social media platform accessible with a Canadian Internet Protocol (IP) address.\nHealth Canada said it will monitor compliance with the injunction and may take further action —including referring the matter for prosecution or filing an application for contempt — if the company does not comply.\nHealth risks drive Canada's peptide crackdown\nIn Canada, injectable peptides are classified as prescription drugs and must receive authorisation from Health Canada before they can be sold.\nThese authorised peptide medications should only be used under the supervision of a licensed healthcare professional, such as a doctor, for the treatment of specific medical conditions.\nIn December 2023, the Department of Health warned consumers against purchasing unauthorised injectable peptides from Canlab Research due to the significant health risks associated with these products.\nIn April of this year, the Department issued an additional advisory, cautioning consumers about injecting peptides purchased online, emphasising the dangers of illegal peptide products.\nUnauthorised and unregulated peptide drugs can be dangerous and may contain ingredients that lack clinical human safety data, proper quality control, and regulatory approval.\nThe products may also be contaminated and cause severe allergic reactions, with the peptides themselves possibly causing a variety of risks, including hormonal and blood sugar imbalances, liver or kidney damage, blood clots and even growth of cancerous tumours.\nHealth Canada urged consumers to look for an eight-digit Drug Identification Number (DIN) on the label of the drugs they purchase as proof of authenticity.","image_url":"/article-image-alias/health-canada-bans-canlab-research-from.png","lang":"en","published_at":"2026-07-30T13:32:34+00:00","fetched_at":"2026-07-30T14:15:11+00:00","status":"read","starred":0,"extract_state":"ok","summary_auto":"Health Canada has been granted a permanent injunction against Canlab Research and its representatives by the Superior Court of Québec, preventing Canlab Research from selling unauthorised injectable peptides in Canada. According to Health Canada, Canlab Research — a Québec-based online retailer — had been selling unauthorised peptide drugs on various websites and promoting them with many unproven health claims.","cluster_id":null,"extract_retries":0,"extract_error":null,"contract_version":"news_item.v1","format_contract_version":"news_item_formats.v1","dedup_url":"https://nutraceuticalbusinessreview.com/health-canada-bans-canlab-research-selling-injectable-peptides","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 2763 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":2763,"summary_length":414,"usable_text_length":2763,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":2763,"summary_length":414}},"news_item":{"id":49839,"canonical_url":"https://nutraceuticalbusinessreview.com/health-canada-bans-canlab-research-selling-injectable-peptides","source_url":"https://nutraceuticalbusinessreview.com/health-canada-bans-canlab-research-selling-injectable-peptides","title":"Health Canada bans Canlab Research from selling injectable peptides - Nutraceutical Business Review","source_name":"Nutraceutical Business Review","author":null,"published_at":"2026-07-30T13:32:34+00:00","locale":"en","topic":"peptides","tags":[],"rss_summary":"Health Canada bans Canlab Research from selling injectable peptides Nutraceutical Business Review","full_text":"Health Canada has been granted a permanent injunction against Canlab Research and its representatives by the Superior Court of Québec, preventing Canlab Research from selling unauthorised injectable peptides in Canada.\nAccording to Health Canada, Canlab Research — a Québec-based online retailer — had been selling unauthorised peptide drugs on various websites and promoting them with many unproven health claims.\nIt had continued despite repeated enforcement actions by Health Canada, including a Ministerial Order directing the company to cease advertising and selling unauthorised health products because of the health risks to Canadians.\nSelling unauthorised prescription drugs or making false or misleading claims to prevent, treat or cure illnesses is illegal in Canada.\nInjunction blocks Canlab’s sales and advertising\nUnder the injunction, Canlab Research cannot manufacture, test, distribute or sell unauthorised injectable peptides. It is also banned from assisting others in doing the same.\nCanlab Research cannot advertise (or assist others in advertising) these products, including on any website or social media platform accessible with a Canadian Internet Protocol (IP) address.\nHealth Canada said it will monitor compliance with the injunction and may take further action —including referring the matter for prosecution or filing an application for contempt — if the company does not comply.\nHealth risks drive Canada's peptide crackdown\nIn Canada, injectable peptides are classified as prescription drugs and must receive authorisation from Health Canada before they can be sold.\nThese authorised peptide medications should only be used under the supervision of a licensed healthcare professional, such as a doctor, for the treatment of specific medical conditions.\nIn December 2023, the Department of Health warned consumers against purchasing unauthorised injectable peptides from Canlab Research due to the significant health risks associated with these products.\nIn April of this year, the Department issued an additional advisory, cautioning consumers about injecting peptides purchased online, emphasising the dangers of illegal peptide products.\nUnauthorised and unregulated peptide drugs can be dangerous and may contain ingredients that lack clinical human safety data, proper quality control, and regulatory approval.\nThe products may also be contaminated and cause severe allergic reactions, with the peptides themselves possibly causing a variety of risks, including hormonal and blood sugar imbalances, liver or kidney damage, blood clots and even growth of cancerous tumours.\nHealth Canada urged consumers to look for an eight-digit Drug Identification Number (DIN) on the label of the drugs they purchase as proof of authenticity.","excerpt":"Health Canada has been granted a permanent injunction against Canlab Research and its representatives by the Superior Court of Québec, preventing Canlab Research from selling unauthorised injectable peptides in Canada. According to Health Canada, Canlab Research — a Québec-based online retailer — had been selling unauthorised peptide drugs on various websites and promoting them with many unproven health claims.","extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 2763 characters.","diagnostics_url":"/api/diagnose?url=https%3A//nutraceuticalbusinessreview.com/health-canada-bans-canlab-research-selling-injectable-peptides","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 2763 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":2763,"summary_length":414,"usable_text_length":2763,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":2763,"summary_length":414}}},"display_formats":["compact","card","full","digest_section","json"]},"daily_stack_record":{"title":"Health Canada bans Canlab Research from selling injectable peptides - Nutraceutical Business Review","url":"https://nutraceuticalbusinessreview.com/health-canada-bans-canlab-research-selling-injectable-peptides","summary":"Health Canada has been granted a permanent injunction against Canlab Research and its representatives by the Superior Court of Québec, preventing Canlab Research from selling unauthorised injectable peptides in Canada. According to Health Canada, Canlab Research — a Québec-based online retailer — had been selling unauthorised peptide drugs on various websites and promoting them with many unproven health claims.","source":"Nutraceutical Business Review","date":"2026-07-30T13:32:34+00:00","content":"Health Canada has been granted a permanent injunction against Canlab Research and its representatives by the Superior Court of Québec, preventing Canlab Research from selling unauthorised injectable peptides in Canada.\nAccording to Health Canada, Canlab Research — a Québec-based online retailer — had been selling unauthorised peptide drugs on various websites and promoting them with many unproven health claims.\nIt had continued despite repeated enforcement actions by Health Canada, including a Ministerial Order directing the company to cease advertising and selling unauthorised health products because of the health risks to Canadians.\nSelling unauthorised prescription drugs or making false or misleading claims to prevent, treat or cure illnesses is illegal in Canada.\nInjunction blocks Canlab’s sales and advertising\nUnder the injunction, Canlab Research cannot manufacture, test, distribute or sell unauthorised injectable peptides. It is also banned from assisting others in doing the same.\nCanlab Research cannot advertise (or assist others in advertising) these products, including on any website or social media platform accessible with a Canadian Internet Protocol (IP) address.\nHealth Canada said it will monitor compliance with the injunction and may take further action —including referring the matter for prosecution or filing an application for contempt — if the company does not comply.\nHealth risks drive Canada's peptide crackdown\nIn Canada, injectable peptides are classified as prescription drugs and must receive authorisation from Health Canada before they can be sold.\nThese authorised peptide medications should only be used under the supervision of a licensed healthcare professional, such as a doctor, for the treatment of specific medical conditions.\nIn December 2023, the Department of Health warned consumers against purchasing unauthorised injectable peptides from Canlab Research due to the significant health risks associated with these products.\nIn April of this year, the Department issued an additional advisory, cautioning consumers about injecting peptides purchased online, emphasising the dangers of illegal peptide products.\nUnauthorised and unregulated peptide drugs can be dangerous and may contain ingredients that lack clinical human safety data, proper quality control, and regulatory approval.\nThe products may also be contaminated and cause severe allergic reactions, with the peptides themselves possibly causing a variety of risks, including hormonal and blood sugar imbalances, liver or kidney damage, blood clots and even growth of cancerous tumours.\nHealth Canada urged consumers to look for an eight-digit Drug Identification Number (DIN) on the label of the drugs they purchase as proof of authenticity.","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//nutraceuticalbusinessreview.com/health-canada-bans-canlab-research-selling-injectable-peptides","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 2763 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 2763 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":2763,"summary_length":414,"usable_text_length":2763,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":2763,"summary_length":414}},"tags":[]},"fallback_formats":["markdown","json","html"],"actions":{"read":"/item/49839","export_markdown":"/api/items/49839/export?format=markdown","export_json":"/api/items/49839/export?format=json","diagnose":"/api/diagnose?url=https%3A//nutraceuticalbusinessreview.com/health-canada-bans-canlab-research-selling-injectable-peptides"},"formats":{"full":{"id":49839,"title":"Health Canada bans Canlab Research from selling injectable peptides - Nutraceutical Business Review","url":"https://nutraceuticalbusinessreview.com/health-canada-bans-canlab-research-selling-injectable-peptides","source":"Nutraceutical Business Review","author":null,"published_at":"2026-07-30T13:32:34+00:00","locale":"en","topic":"peptides","tags":[],"excerpt":"Health Canada has been granted a permanent injunction against Canlab Research and its representatives by the Superior Court of Québec, preventing Canlab Research from selling unauthorised injectable peptides in Canada. According to Health Canada, Canlab Research — a Québec-based online retailer — had been selling unauthorised peptide drugs on various websites and promoting them with many unproven health claims.","full_text":"Health Canada has been granted a permanent injunction against Canlab Research and its representatives by the Superior Court of Québec, preventing Canlab Research from selling unauthorised injectable peptides in Canada.\nAccording to Health Canada, Canlab Research — a Québec-based online retailer — had been selling unauthorised peptide drugs on various websites and promoting them with many unproven health claims.\nIt had continued despite repeated enforcement actions by Health Canada, including a Ministerial Order directing the company to cease advertising and selling unauthorised health products because of the health risks to Canadians.\nSelling unauthorised prescription drugs or making false or misleading claims to prevent, treat or cure illnesses is illegal in Canada.\nInjunction blocks Canlab’s sales and advertising\nUnder the injunction, Canlab Research cannot manufacture, test, distribute or sell unauthorised injectable peptides. It is also banned from assisting others in doing the same.\nCanlab Research cannot advertise (or assist others in advertising) these products, including on any website or social media platform accessible with a Canadian Internet Protocol (IP) address.\nHealth Canada said it will monitor compliance with the injunction and may take further action —including referring the matter for prosecution or filing an application for contempt — if the company does not comply.\nHealth risks drive Canada's peptide crackdown\nIn Canada, injectable peptides are classified as prescription drugs and must receive authorisation from Health Canada before they can be sold.\nThese authorised peptide medications should only be used under the supervision of a licensed healthcare professional, such as a doctor, for the treatment of specific medical conditions.\nIn December 2023, the Department of Health warned consumers against purchasing unauthorised injectable peptides from Canlab Research due to the significant health risks associated with these products.\nIn April of this year, the Department issued an additional advisory, cautioning consumers about injecting peptides purchased online, emphasising the dangers of illegal peptide products.\nUnauthorised and unregulated peptide drugs can be dangerous and may contain ingredients that lack clinical human safety data, proper quality control, and regulatory approval.\nThe products may also be contaminated and cause severe allergic reactions, with the peptides themselves possibly causing a variety of risks, including hormonal and blood sugar imbalances, liver or kidney damage, blood clots and even growth of cancerous tumours.\nHealth Canada urged consumers to look for an eight-digit Drug Identification Number (DIN) on the label of the drugs they purchase as proof of authenticity.","reading_time_min":2,"extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 2763 characters.","diagnostics_url":"/api/diagnose?url=https%3A//nutraceuticalbusinessreview.com/health-canada-bans-canlab-research-selling-injectable-peptides","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 2763 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":2763,"summary_length":414,"usable_text_length":2763,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":2763,"summary_length":414}}},"quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 2763 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":2763,"summary_length":414,"usable_text_length":2763,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":2763,"summary_length":414}},"actions":{"read":"/item/49839","export_markdown":"/api/items/49839/export?format=markdown","export_json":"/api/items/49839/export?format=json","diagnose":"/api/diagnose?url=https%3A//nutraceuticalbusinessreview.com/health-canada-bans-canlab-research-selling-injectable-peptides"}},"digest":{"id":49839,"title":"Health Canada bans Canlab Research from selling injectable peptides - Nutraceutical Business Review","url":"https://nutraceuticalbusinessreview.com/health-canada-bans-canlab-research-selling-injectable-peptides","source":"Nutraceutical Business Review","topic":"peptides","published_at":"2026-07-30T13:32:34+00:00","excerpt":"Health Canada has been granted a permanent injunction against Canlab Research and its representatives by the Superior Court of Québec, preventing Canlab Research from selling unauthorised injectable peptides in Canada. According to Health Canada, Canlab Research — a Québec-based…","quality_bucket":"high","quality_reason":"High confidence: full text extraction produced 2763 characters.","reading_time_min":2,"cluster_id":null},"card":{"display_title":"Health Canada bans Canlab Research from selling injectable peptides - Nutraceutical Business Review","subtitle":"Nutraceutical Business Review · 2026-07-30","summary":"Health Canada has been granted a permanent injunction against Canlab Research and its representatives by the Superior Court of Québec, preventing Canlab Research from selling unauthorised injectable peptides in Canada.…","badges":["quality:high"],"links":{"read":"/item/49839","original":"https://nutraceuticalbusinessreview.com/health-canada-bans-canlab-research-selling-injectable-peptides","diagnose":"/api/diagnose?url=https%3A//nutraceuticalbusinessreview.com/health-canada-bans-canlab-research-selling-injectable-peptides"},"quality_warning":null},"export":{"title":"Health Canada bans Canlab Research from selling injectable peptides - Nutraceutical Business Review","url":"https://nutraceuticalbusinessreview.com/health-canada-bans-canlab-research-selling-injectable-peptides","summary":"Health Canada has been granted a permanent injunction against Canlab Research and its representatives by the Superior Court of Québec, preventing Canlab Research from selling unauthorised injectable peptides in Canada. According to Health Canada, Canlab Research — a Québec-based online retailer — had been selling unauthorised peptide drugs on various websites and promoting them with many unproven health claims.","source":"Nutraceutical Business Review","date":"2026-07-30T13:32:34+00:00","content":"Health Canada has been granted a permanent injunction against Canlab Research and its representatives by the Superior Court of Québec, preventing Canlab Research from selling unauthorised injectable peptides in Canada.\nAccording to Health Canada, Canlab Research — a Québec-based online retailer — had been selling unauthorised peptide drugs on various websites and promoting them with many unproven health claims.\nIt had continued despite repeated enforcement actions by Health Canada, including a Ministerial Order directing the company to cease advertising and selling unauthorised health products because of the health risks to Canadians.\nSelling unauthorised prescription drugs or making false or misleading claims to prevent, treat or cure illnesses is illegal in Canada.\nInjunction blocks Canlab’s sales and advertising\nUnder the injunction, Canlab Research cannot manufacture, test, distribute or sell unauthorised injectable peptides. It is also banned from assisting others in doing the same.\nCanlab Research cannot advertise (or assist others in advertising) these products, including on any website or social media platform accessible with a Canadian Internet Protocol (IP) address.\nHealth Canada said it will monitor compliance with the injunction and may take further action —including referring the matter for prosecution or filing an application for contempt — if the company does not comply.\nHealth risks drive Canada's peptide crackdown\nIn Canada, injectable peptides are classified as prescription drugs and must receive authorisation from Health Canada before they can be sold.\nThese authorised peptide medications should only be used under the supervision of a licensed healthcare professional, such as a doctor, for the treatment of specific medical conditions.\nIn December 2023, the Department of Health warned consumers against purchasing unauthorised injectable peptides from Canlab Research due to the significant health risks associated with these products.\nIn April of this year, the Department issued an additional advisory, cautioning consumers about injecting peptides purchased online, emphasising the dangers of illegal peptide products.\nUnauthorised and unregulated peptide drugs can be dangerous and may contain ingredients that lack clinical human safety data, proper quality control, and regulatory approval.\nThe products may also be contaminated and cause severe allergic reactions, with the peptides themselves possibly causing a variety of risks, including hormonal and blood sugar imbalances, liver or kidney damage, blood clots and even growth of cancerous tumours.\nHealth Canada urged consumers to look for an eight-digit Drug Identification Number (DIN) on the label of the drugs they purchase as proof of authenticity.","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//nutraceuticalbusinessreview.com/health-canada-bans-canlab-research-selling-injectable-peptides","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 2763 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 2763 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":2763,"summary_length":414,"usable_text_length":2763,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":2763,"summary_length":414}},"tags":[],"format_contract_version":"news_item_formats.v1"}}}